This page's slug names a specific risk figure. It is not asserted here, because no source consulted for this hub establishes it.
That is the whole subject. Precise numbers linking obesity to low testosterone circulate constantly — in clinic marketing, in health articles, in the source material this hub was originally asked to port. A decimal place makes a claim feel measured. It does not make it true.
What is actually documented
The relationship between androgens and obesity is real and reviewed as a subject in its own right.[1] What the careful literature does not do is reduce it to a single portable statistic, and the reason is instructive.
A 2018 review titled Hypogonadism and male obesity: Focus on unresolved questions is explicit in its framing.[2] "Unresolved questions" is not throat-clearing — it is an accurate description of a field where the direction of causation, the effect of intervention, and the right diagnostic thresholds in obese men are all still contested.
A field with unresolved questions does not produce clean odds ratios that travel well.
Why unsourced statistics are worse than no statistic
They cannot be checked, so they cannot be corrected. A claim with no origin has no mechanism for being found wrong. It simply persists.
They crowd out the real finding. "Obesity is associated with lower testosterone through several mechanisms including aromatisation and altered SHBG" is true, useful, and citable.[1][3] A spurious odds ratio adds nothing to it while sounding more authoritative.
On YMYL medical pages they are a liability. A statistic a reader cannot verify is a claim the publisher cannot defend.
What can be said with citations
Adipose tissue converts testosterone to estradiol via aromatase, and obesity alters SHBG — both changing the relationship between total and free testosterone.[1][3] See the fat cell problem.
Free testosterone should be measured when total sits near the lower limit of normal or when a condition altering SHBG is present — obesity being one.[4]
Body composition responds to testosterone, on a 12–16 week onset.[5]
The direction of causation is unresolved.[2]
That is a complete, honest account of the metabolism story, and it contains no number that cannot be traced.
How this hub handles it
Every clinical claim is verified against primary literature, and figures that cannot be attributed are dropped, not softened. Not rephrased as "studies suggest," not hedged into "up to" — removed.
The same rule caught a fabricated DOI shipping in a live article on this site: an identifier that looked entirely plausible and resolved to nothing.
Frequently asked questions
So how much does obesity raise the risk of low testosterone? No figure is given here because none was verifiable. The mechanisms and the association are documented.[1][2]
Does that mean the link isn't real? The link is real and well described.[1] What is missing is a specific, traceable risk statistic.
Why keep the number in the URL? The slug is fixed so the old address still resolves. The page title and content reflect what the evidence supports.
Where the story goes next
Everything in this season concerns men. Women make testosterone too, and the research gap there is its own subject.
Continue with testosterone therapy for women.
References
5 sources
- Allan CA, McLachlan RI. Androgens and obesity. Curr Opin Endocrinol Diabetes Obes. 2010;17(3):224–232. doi:10.1097/MED.0b013e3283398ee2 · PMID 20418719
- Grossmann M. Hypogonadism and male obesity: Focus on unresolved questions. Clin Endocrinol (Oxf). 2018;89(1):11–21. doi:10.1111/cen.13723 · PMID 29683196
- Goldman AL, Bhasin S, Wu FCW, et al. A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. 2017;38(4):302–324. doi:10.1210/er.2017-00025 · PMID 28673039
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364
- Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol. 2011;165(5):675–685. doi:10.1530/EJE-11-0221 · PMID 21753068
Practical questions about membership, labs and using the spray are answered in the Learn Hub FAQ.